$ 1.540
Updated 16/02/2019
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 1,480,880
High $ 1.550
Low $ 1.480
Open $ 1.540
ISIN
Prev close $ 1.550
# of shares 82.32M
Market cap 126.78M USD
Intraday

Market closed
Trevena Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  1.54 2.7% Stock price increasing 181.4% Stock price increasing 140.6% Stock price increasing -1.9% Stock price decreasing -8.6% Stock price decreasing
Powered by TradingView

News about Trevena Inc

  • English
  • Regulatory news

Company profile

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 February 2019 03:12:15
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20190215.1 - EUROWEB3 - 2019-02-18 04:12:15 - 2019-02-18 03:12:15 - 1000 - Website: OKAY